Home/Filings/4/0001140361-22-004585
4//SEC Filing

Georgantas Robert William III 4

Accession 0001140361-22-004585

CIK 0001439725other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 7:08 PM ET

Size

7.5 KB

Accession

0001140361-22-004585

Insider Transaction Report

Form 4
Period: 2022-02-08
Georgantas Robert William III
DirectorSVP, Rsrch & Trans'l Science
Transactions
  • Award

    Restricted Stock Units

    2022-02-08+31,53731,537 total
    Common Stock (31,537 underlying)
  • Award

    Restricted Stock Units

    2022-02-08+22,05322,053 total
    Common Stock (22,053 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
  • [F3]These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001827728

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 7:08 PM ET
Size
7.5 KB